- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT01043718
Delivering an Evidence-Based Lifestyle Intervention Via the Internet: A Randomized Controlled Study
Hershey Medical Center and the University of Pittsburgh are doing a research study to help meet the needs of the adult population at risk for diabetes and heart disease. This study will provide a web-based program that aims to help participants to develop healthier eating habits, lose weight and become more physically active. The Internet-based materials will teach participants about healthy eating and physical activity and will ask them to incorporate the information they learn into their daily lives.
The purpose of this study is to evaluate the effectiveness of online lifestyle change programs to promote weight loss, healthy eating and physical activity patterns, in the interest of reducing risk for and adverse outcomes of type 2 diabetes (T2D) and cardiovascular disease (CVD).
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Werkelijk)
Fase
- Fase 2
- Fase 3
Contacten en locaties
Studie Locaties
-
-
Pennsylvania
-
Hershey, Pennsylvania, Verenigde Staten, 17033
- Penn State Milton S. Hershey Medical Center
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Please note: Only individuals who receive primary care at one of the Internal Medicine clinics at Milton S. Hershey Medical Center in Hershey, PA, are eligible for this study.
Inclusion Criteria:
- Age between 18 and 80 years old
- Obese based on World Health Organization criteria (BMI>30kg/m2)
- Receiving primary care from and referred by a provider at one of the Internal Medicine clinics at Milton S. Hershey Medical Center in Hershey, PA
- Able to understand and sign an informed consent document
- Able to communicate with the investigator and understand the requirements of this study
Exclusion Criteria
- Primary care provider determines that the individual is unable to safely undertake moderately intense unsupervised physical activity (the equivalent of 30 minutes of brisk walking)
- Primary care provider determines that the individual has inadequate cognitive function to participate in either active intervention curricula
- Women who are pregnant, who are planning to become pregnant in the next two years, or who become pregnant during the study
- Women who are breastfeeding
- Prisoners
- Children
- Individuals who are planning to have bariatric surgery or who have had bariatric surgery in the past two years
- Individuals with uncontrolled hypertension (systolic blood pressure (SBP) >165, diastolic blood pressure (DBP) >100)
- Individuals with an edematous state that interferes with body weight assessment (e.g., severe congestive heart failure, end- stage renal disease, or ascites),
- Individuals already using weight loss therapy
- Individuals with an inability to learn adequately from English language audio-taped materials
- Individuals with a lack of high-speed Internet access (Internet access will be based on participant perception; for example, participants could use computers belonging to friends, relatives, or libraries if they feel that they can access them regularly)
- Individuals without access to a scale
- Individuals unable to attend an Orientation session at Hershey Medical Center in Hershey, PA
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Experimenteel: More-Intensive
|
The online lifestyle intervention will include elements of a behavioral lifestyle program developed by the Diabetes Prevention Program.
The program will assist individual participants with establishing appropriate weight loss goals, implementing dietary recommendations (including analysis of current diet), and defining exercise programs.
The program curriculum provides standard information about healthy lifestyle, and behavioral techniques for integrating them into daily living.
In each lesson, patients provide feedback about how they interpret the information, and ideas for integrating it into their lives.
|
Actieve vergelijker: Less-Intensive
|
The participants will be provided with the information to access the online Diabetes Prevention Program (DPP) intervention materials.
Following the original DPP trial, all DPP materials were placed online for the public to access.
This group will receive a lifestyle counseling session and tools to facilitate their intervention.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
---|---|
Change in body weight (kg)
Tijdsspanne: 6 months, 12 months, 18 months
|
6 months, 12 months, 18 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
---|---|
Percentage of body weight lost
Tijdsspanne: 6 months, 12 months, 18 months
|
6 months, 12 months, 18 months
|
Change in blood pressure (mm Hg)
Tijdsspanne: 6 months, 12 months, 18 months
|
6 months, 12 months, 18 months
|
Change in health-related quality of life as determined by the RAND-36 PCS or MCS
Tijdsspanne: 6 months, 12 months, 18 months
|
6 months, 12 months, 18 months
|
Change in physical activity (steps per day)
Tijdsspanne: 6 months, 12 months, 18 months
|
6 months, 12 months, 18 months
|
Change in dietary pattern
Tijdsspanne: 6 months, 12 months, 18 months
|
6 months, 12 months, 18 months
|
Satisfaction with program
Tijdsspanne: 6 months, 12 months, 18 months
|
6 months, 12 months, 18 months
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Kathleen McTigue, MD MS MPH, University of Pittsburgh
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- HMC32877
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op More-Intensive
-
Galapagos NVBeëindigdAtopische dermatitisDuitsland, Hongarije, Polen, Slowakije, Verenigd Koninkrijk
-
Hospital Universitario La FeVoltooidColorectale kankerSpanje
-
Hospital Universitario La FeOnbekendColorectale chirurgie voor stadium II / III primaire colorectale kanker
-
Carol Davila University of Medicine and PharmacyWervingEndoscopie van het bovenste deel van het maagdarmkanaalRoemenië
-
Alexandria UniversityVoltooidPijn, postoperatief | Anesthesie, lokaal | Acetabulaire breuk | ZenuwpijnEgypte
-
City of Hope Medical CenterNational Cancer Institute (NCI)WervingChronische lymfatische leukemie | Klein lymfocytisch lymfoomVerenigde Staten
-
OHSU Knight Cancer InstituteOregon Health and Science University; Incyte CorporationWervingChronische lymfatische leukemieVerenigde Staten
-
City of Hope Medical CenterNational Cancer Institute (NCI)WervingChronische graft-versus-hostziekte | Hematologische en lymfocytische stoornis | Steroïde refractaire graft-versus-hostziekteVerenigde Staten
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)WervingRecidiverend mantelcellymfoom | Refractair mantelcellymfoomVerenigde Staten
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Incyte Corporation; Ipsen; BeiGeneWervingRecidiverend diffuus grootcellig B-cellymfoom | Refractair diffuus grootcellig B-cellymfoom | Hoogwaardig B-cellymfoom | Graad 3b folliculair lymfoom | Getransformeerd non-Hodgkin-lymfoom | Hoogwaardig B-cellymfoom met herschikkingen van MYC en BCL2 en/of BCL6Verenigde Staten